Two new HIV cure cases to be presented in Rio

Two patients, known as Ascent and Kansas City, will be presented as the 12th and 13th cases of HIV cure or prolonged remission after stem cell transplants during an international AIDS conference in Rio de Janeiro.

The information was anticipated by immunologist Christian Gaebler, from Charité Universitätsmedizin Berlin, during a pre-conference. The cases will be detailed in a session dedicated to HIV cure on Wednesday (29).

Gaebler stated that patient Ascent will be number 12 and the one from Kansas City number 13, describing the results as really fascinating. No additional clinical details about the Kansas City patient were revealed.

All 13 cured or in remission patients also had leukemia or another hematological cancer that required the transplant, a high-risk procedure indicated only for fatal diseases. The first recorded case was that of Timothy Ray Brown, the Berlin patient, in 2009.

Researchers are investigating additional mechanisms, such as neutralizing antibodies, that may contribute to virus control without the full CCR5-delta32 mutation.

Liittyvät artikkelit

Microscopic view of enhanced natural killer cells attacking cancer cells due to a drug developed by McGill researchers.
AI:n luoma kuva

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

A small study has found that CAR-T cell therapy may offer a new way to manage HIV over the long term. The approach, already used to treat certain cancers, involves engineering a patient’s own immune cells.

Raportoinut AI

Eight patients with Parkinson's disease have received transplants of dopamine-producing stem cells in a study at Lund University. The first results show promising signs of cell survival without serious side effects.

Researchers in Sweden have created insulin-producing cells from human stem cells that reversed diabetes symptoms when transplanted into mice. The cells matured after placement in the eye and maintained glucose regulation for months. The work was published in Stem Cell Reports.

Raportoinut AI

São Paulo state health authorities have ruled out the second suspected Ebola case in the state this year. The patient, a 31-year-old Brazilian woman who returned from the Democratic Republic of Congo, tested negative.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää